Skip to main content
Explore URMC
menu

Carla Falkson, M.B.Ch.B., M.Med., M.D.

Publications

Showing all 117 journal articles & 24 books available

Journal Articles

3/4/2021
Stringer-Reasor EM, May JE, Olariu E, Caterinicchia V, Li Y, Chen D, Della Manna DL, Rocque GB, Vaklavas C, Falkson CI, Nabell LM, Acosta EP, Forero-Torres A, Yang ES. "An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer." Breast cancer research : BCR.. 2021 Mar 4; 23(1):30. Epub 2021 Mar 04.

11/2020
Carpenter J, Forero A, Falkson CI, Nabell LM, De Los Santos JF, Krontiras H, Bland KI, Li Y, Bae S. "Less Toxic Chemotherapy in Locally Advanced Breast Cancer." Southern medical journal.. 2020 Nov 0; 113(11):559-563.

9/15/2020
Kizub DA, Miao J, Schubert MM, Paterson AHG, Clemons M, Dees EC, Ingle JN, Falkson CI, Barlow WE, Hortobagyi GN, Gralow JR. "Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2020 Sep 15; Epub 2020 Sep 15.

7/15/2020
Moftakhar B, Lekkala M, Strawderman M, Smith TC, Meacham P, Fitzgerald B, Falkson CI, Dhakal A. "Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer." Breast cancer research and treatment.. 2020 Jul 15; Epub 2020 Jul 15.

7/9/2020
Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Shen F, Storniolo AMV, Badve S, Ballinger TJ, Chang CL, Zhong Y, Savran C, Miller KD, Schneider BP. "Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial." JAMA oncology.. 2020 Jul 9; Epub 2020 Jul 09.

2020
Moftakhar B, Kharel P, Niraula S, Gandhi S, Falkson C, Dhakal A. "Neratinib-Induced Duodenal Ulcer: A Case Report." Breast cancer : basic and clinical research.. 2020 14:1178223420935871. Epub 2020 Jun 23.

10/31/2019
Hortobagyi GN, Paterson AHG, Miao JL, Lew DL, Stopeck AT, Hayes DF, Hershman DL, Schubert MM, Clemons M, Van Poznak CH, Barlow WE, Dees EC, Falkson CI, Elias AD, Messino MJ, Margolis JH, Dakhil SR, Chew HK, Dammann KZ, Abrams JS, Livingston RB, Ingle JN, Gralow JR. "Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307." Journal of the National Cancer Institute.. 2019 Oct 31; Epub 2019 Oct 31.

9/1/2018
Hamilton E, Vo A, Gray T, Chamberlain M, Bedard PL, Chaves J, Conlin A, Welch S, Krop I, Khan Q, Falkson C, Aucoin N, Ferrario C, Borges VF. "Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial." JAMA oncology.. 2018 Sep 1; 4(9):1214-1220.

7/1/2018
Cardoso F, Villanueva C, Özgüroglu M, Azevedo SJ, Cruz FM, Debled M, Hegg R, Bachelot T, Toyama T, Jeong J, Srimuninnimit V, Gradishar WJ, Arce C, Ridolfi A, Lin C, Falkson C, Royce M. "Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial." JAMA oncology.. 2018 Jul 1; 4(7):977-984.

12/2017
Kilgore ML, Yong M, Falkson C, Godby K, Jooste R, Yun H, Delzell E, Sathiakumar N. "Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases." Medical care.. 2017 Dec 0; 55(12):e144-e149.

11/9/2017
Hayes DF, Dowsett M, Bergh J, Pritchard KI, Peto R, McGale P, Taylor C, Davies C, Braybrooke J, Gray R, Pan H. "20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years." The New England journal of medicine.. 2017 Nov 9; 377(19):1836-1846.

9/2017
Sledge GW, Klein P, Falkson CI, Katherine Alpaugh R, Pellegrino CM, Bhalla KN, Meropol NJ, Sparano JA, Swaby RF, Wang M, Zhao F, Goldstein LJ. "A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)." Breast cancer research and treatment.. 2017 Sep 0; 165(2):375-382. Epub 2017 Jun 16.

7/7/2016
Edmiston KK, Park JW, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Liu MC, Haley BB, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Khan QJ, Esserman LJ, Yee D, van 't Veer LJ, Albain KS, Tripathy D, Nanda R, Isaacs C, Kaplan HG, Kemmer KA, Chui SY, Haddad TC, Yau C, Boughey JC, Chien AJ, Buxton MB, DeMichele A, Hogarth M, Hylton NM, Perlmutter J, Paoloni M, Symmans WF, Wallace AM, Berry DA. "Adaptive Randomization of Neratinib in Early Breast Cancer." The New England journal of medicine.. 2016 Jul 7; 375(1):11-22.

7/7/2016
Esserman LJ, Isaacs C, Liu MC, Albain KS, Haddad TC, Boughey JC, Kaplan HG, Wallace AM, Chien AJ, Khan QJ, Yee D, Perlmutter J, Paoloni M, Hylton NM, Hogarth M, Buxton MB, van 't Veer LJ, Yau C, DeMichele A, Symmans WF, Olopade OI, Lang JE, Pusztai L, Berry DA, Sanil A, Hirst GL, Davis SE, Lyandres J, Schwab R, Ewing C, Wood WC, Viscusi RK, Tripathy D, Nanda R, Haley BB, Euhus DM, Edmiston KK, Elias AD, Kemmer KA, Chui SY, Moulder SL, Northfelt DW, Rugo HS. "Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer." The New England journal of medicine.. 2016 Jul 7; 375(1):23-34.

12/1/2015
Kirkwood JM, Butterfield LH, Whiteside TL, Cohen GI, Atkins MB, Ernstoff MS, Margolin KA, Tarhini AA, Zhao F, Lee S, Lawson DH. "Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Dec 1; 33(34):4066-76. Epub 2015 Sep 08.

10/3/2015
"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials." Lancet.. 2015 Oct 3; 386(10001):1341-1352. Epub 2015 Jul 23.

8/20/2015
Van den Abbeele AD, Yap JT, Mayer IA, Falkson CI, Hobday TJ, Dees EC, Richardson AL, Nanda R, Rimawi MF, Ryabin N, Najita JS, Barry WT, Arteaga CL, Wolff AC, Krop IE, Winer EP, Guo H, Lin NU. "Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Aug 20; 33(24):2623-31. Epub 2015 Jul 13.

6/21/2014
Darby S, Wang Z, Wang Y, Whelan T, Peto R, Mannu G, Gray R, Ewertz M, Duane F, Cutter D, Correa C, Taylor C, McGale P. "Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials." Lancet.. 2014 Jun 21; 383(9935):2127-35. Epub 2014 Mar 19.

1/2013
Kilgore ML, Arora T, Blackburn J, Chia V, Yong M, Falkson C, Morrisey MA, Delzell E, Sathiakumar N. "Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006." Lung India : official organ of Indian Chest Society.. 2013 Jan 0; 30(1):20-6.

7/2012
Wolmark N, Lembersky BC, Fehrenbacher L, Falkson CI, King KM, Weir LM, Brufsky AM, Dakhil S, Lad T, Baez-Diaz L, Gralow JR, Robidoux A, Perez EA, Zheng P, Geyer CE, Swain SM, Costantino JP, Mamounas EP, Anderson SJ, Paterson AH. "Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial." The Lancet. Oncology.. 2012 Jul 0; 13(7):734-42. Epub 2012 Jun 14.

6/15/2012
Slamon DJ, Betting DJ, Stern HM, Quinaux E, Stinson J, Seshagiri S, Zhao Y, Buyse M, Mackey J, Driga A, Damaraju S, Sliwkowski MX, Robert NJ, Valero V, Crown J, Falkson C, Brufsky A, Pienkowski T, Eiermann W, Martin M, Bee V, Marathe O, Hurvitz SA, Timmerman JM. "Analysis of Fc? receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2012 Jun 15; 18(12):3478-86. Epub 2012 Apr 13.

1/2012
Kilgore ML, Brill I, Arora T, Blackburn J, Chia V, Yong M, Falkson C, Morrisey MA, Delzell E, Sathiakumar N. "Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006." Breast cancer research and treatment.. 2012 Jan 0; 131(1):231-8. Epub 2011 Aug 13.

11/12/2011
Peto R, Wang Y, Whelan T, Pierce L, Gray R, Godwin J, Ewertz M, Davies C, Cutter D, Clarke M, Arriagada R, Taylor C, Correa C, McGale P, Darby S. "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials." Lancet.. 2011 Nov 12; 378(9804):1707-16. Epub 2011 Oct 19.

10/6/2011
Tabah-Fisch I, Lindsay MA, Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Riva A, Chan A, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Pawlicki M, Crown J. "Adjuvant trastuzumab in HER2-positive breast cancer." The New England journal of medicine.. 2011 Oct 6; 365(14):1273-83.

8/27/2011
Peto R, Ingle J, Dowsett M, Wang YC, Taylor C, Pan HC, McGale P, Darby S, Cutter D, Clarke M, Gray R, Godwin J, Davies C. "Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials." Lancet.. 2011 Aug 27; 378(9793):771-84. Epub 2011 Jul 28.

6/23/2011
Farmer P, Gelmon KA, Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Tu D, Richardson H. "Exemestane for breast-cancer prevention in postmenopausal women." The New England journal of medicine.. 2011 Jun 23; 364(25):2381-91. Epub 2011 Jun 04.

6/2011
Kilgore ML, Arora T, Blackburn J, Chia V, Yong M, Falkson C, Morrisey MA, Delzell E, Sathiakumar N. "Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006." Prostate cancer and prostatic diseases.. 2011 Jun 0; 14(2):177-83. Epub 2011 Mar 15.

1/2011
Benson AB, Mulcahy MF, Mason BA, Slabber CF, Xu R, Falkson CI, Rossman JF. "Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group." Gastrointestinal cancer research : GCR.. 2011 Jan 0; 4(1):9-14.

8/1/2010
Forero-Torres A, Saleh MN, Galleshaw JA, Jones CF, Shah JJ, Percent IJ, Nabell LM, Carpenter JT, Falkson CI, Krontiras H, Urist MM, Bland KI, De Los Santos JF, Meredith RF, Caterinicchia V, Bernreuter WK, O'Malley JP, Li Y, LoBuglio AF. "Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer." Clinical breast cancer.. 2010 Aug 1; 10(4):275-80.

2010
Cassileth PA, Rowe JM, Falkson CI, Venkatraj U, Yao X, Dutcher JP, Wiernik PH. "Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)." Journal of immunotherapy.. 2010 33(9):1006-9.

2010
Darby S, Solin L, Bijker N, Peto R, Davies C, Clarke M, Wang Y, Taylor C, McGale P, Correa C. "Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast." Journal of the National Cancer Institute. Monographs.. 2010 2010(41):162-77.

12/2009
Swaby R;Wang M; Sparano J;Bhalla K, Meropol N; Falkson C; Pellegrino C; Klein P; Goldstein L;Sledge Jr G. "A Phase II Study of the Histone Deacetylase Inhibitor, Vorinostat, in Combination with Trastuzumab in Patients with Advanced Metastatic and/or Local Chest Wall Recurrent HER-2 Amplified Breast Cancer Resistant to Trastuzumab-Containing Therapy: (E1104) a Trial of the Eastern Cooperative Oncology Group." Cancer Research. 2009; 69(suppl 24).

2009
Woods J, Basch S, Bent S, Boon H, Burke D, Costa D, Falkson C, Basch E, Giese N, Hashmi S, Mukarjee S, Papaliodis G, Seamon E, Tanguay-Colucci S, Weissner W, Goble M, Ulbricht C. "An evidence-based systematic review of bilberry (Vaccinium myrtillus) by the Natural Standard Research Collaboration." Journal of dietary supplements.. 2009 6(2):162-200.

7/7/2008
Fouad M, Cofield S, Falkson C, Funkhouser E, Waterbor JW, Worthington J. "Receipt of standard breast cancer treatment by African American and White women." International journal of medical sciences.. 2008 Jul 7; 5(4):181-8. Epub 2008 Jul 07.

1/5/2008
Wood WC, Pritchard KI, Peto R, Gray R, Goldhirsch A, Godwin J, Gelber RD, Davies C, Darby SC, Coates AS, Clarke M. "Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials." Lancet.. 2008 Jan 5; 371(9606):29-40.

2008
Worthington J; Funkhouser E; Waterbor JW; Falkson C;Cofield S; Fouad M. "Accuracy of registry breast cancer treatment data among cases treated in urban hospitals". Journal of Registry Management. 2008; 35(2): 75-80.

6/1/2007
Zhang HG, Falkson C, Grizzle WE, Kimberly R, Cong Y, Li C, Zhang L, Liu Y, Wang J, Su K, Liu C, Yu S. "Tumor exosomes inhibit differentiation of bone marrow dendritic cells." The Journal of immunology : official journal of the American Association of Immunologists.. 2007 Jun 1; 178(11):6867-75.

12/17/2005
Wang Y, Taylor C, Peto R, McHugh T, McGale P, MacKinnon E, James S, Hicks C, Gray R, Godwin J, Evans V, Elphinstone P, Davies C, Darby S, Collins R, Clarke M. "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials." Lancet.. 2005 Dec 17; 366(9503):2087-106.

2/2005
Prince HM, Dale B, Matthews JP, Richards K, Seymour JF, Januszewicz H, Wolf M, Falkson C, Leahy M, Abdi E, Smith C, Herbert KE, Biagi JJ. "A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma." Leukemia & lymphoma.. 2005 Feb 0; 46(2):197-206.

2005
"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials." Lancet.. 2005 365(9472):1687-717.

2005
His P, Burillon JP, Lategan A, Gasmi J, Falkson CI, Smith BL, Falkson G, Goedhals L. "Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience." Anticancer research.. 2005 25(3c):2489-92.

3/2004
Kadish AS, Ho G, Burk R, Weller E, Wang Y, Falkson CI, Frederickson HL, Levy D, Wadler S. "A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96." Gynecologic oncology.. 2004 Mar 0; 92(3):957-64.

2004
Falkson Carla I. "The Treatment of Metastatic Breast Cancer: Overview". Medical Professional Magazine Alabama. 2004; 1(1).

3/15/2003
Pinter T, Murawsky M, Azli N, Kennedy I, Leonard R, Vorobiof D, Krzakowski M, Riva A, Nabholtz JM, Campos D, Szanto J, Martin M, Chan S, Pienkowski T, Zaluski J, Falkson C, Pouillart P. "Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2003 Mar 15; 21(6):968-75.

2003
Edmonson JH, Ryan LM, Falkson CI, Hicks DG, Blum RH. "Phase II Study of Ifosfamide+Doxorubicin in Patients With Advanced Synovial Sarcomas (E1793): A Trial of the Eastern Cooperative Oncology Group." Sarcoma.. 2003 7(1):9-11.

6/2002
Spitler L, Falkson C, Retsas S. "Report on the 4th International Conference on the Adjuvant Therapy of Malignant Melanoma held at the Royal College of Physicians, London, UK, 15-16 March 2002." Melanoma research.. 2002 Jun 0; 12(3):A1-4.

2001
Wadler S, Falkson C, Gerstner J, Cella D, Harris LS, Weller E, Schink JC. "Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)." The cancer journal.. 2001 7(2):155-64.

8/2000
Falkson CI, Mertz M, van Rensburg EJ, Yawitch TM. "Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 2000 Aug 0; 90(8):788.

6/2000
Wood WC, Falkson CI, Schaefer PL, O'Neill A, Sparano JA. "Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2000 Jun 0; 18(12):2369-77.

6/2000
Saphner T, Weller EA, Tormey DC, Pandya KJ, Falkson CI, Stewart J, Robert NJ. "21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature." American journal of clinical oncology.. 2000 Jun 0; 23(3):258-62.

5/20/2000
"Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group." Lancet.. 2000 May 20; 355(9217):1757-70.

5/2000
Early Breast Cancer Trialists' Collaborative Group. "Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials." Lancet. 2000; 355(9217): 1757-70.

5/2000
Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, Pandya KJ, Page DL, Robert NJ. "Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2000 May 0; 18(10):2059-69.

3/2000
Falkson G, Falkson C, Lent L, Mertz M, Eremenco S, Chang CH, Cella D, Mullin V. "Development of three African language translations of the FACT-G." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.. 2000 Mar 0; 9(2):139-49.

2/2000
Benson AB, Baez L, Falkson CI, Graham D, Lipsitz S, Asbury RF. "Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293)." American journal of clinical oncology.. 2000 Feb 0; 23(1):45-6.

12/1999
Wood WC, Wolff AC, Falkson CI, Rao RM, Hu P, Sparano JA. "Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1999 Dec 0; 17(12):3828-34.

11/1999
Flinn IW; Lee S; Bennett JM; Falkson CI; Flynn P; Pundaleeka S; Stadtmauer E; Schnel.F; Tallman.M; Rowe.JM. "Phase II trial of fludarabine and cyclophosphamide (Flu/Cy) in patients with previously untreated chronic lymphocytic leukemia: An eastern cooperative oncology group study (E1997)". .BLOOD. 1999; 94(10): 4610.

10/1999
Falkson G, Falkson CI. "A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma." Oncology.. 1999 Oct 0; 57(3):232-5.

8/1999
Falkson CI, McMichael GB. "Carcinoma of unknown primary site--leave it unknown." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1999 Aug 0; 89(8):844-5.

10/1998
Falkson CI, Falkson G, Burger W, Schoeman L, Nel JS, Slabber CF. "A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus." American journal of clinical oncology.. 1998 Oct 0; 21(5):462-5.

10/1998
Falkson CI, Eek RW. "Extended survival in 80 patients with operable, locoregionally recurrent breast cancer treated with chemotherapy." American journal of clinical oncology.. 1998 Oct 0; 21(5):501-4.

9/1998
Falkson C I; Cohen G L; Eek R W; Slabber C F. "Treatment of Melanoma." Specialist Medicine. 1998; : 12-15, 28.

6/1998
Falkson CI, Cohen GL. "Current treatment options for malignant melanoma." Drugs.. 1998 Jun 0; 55(6):791-9.

5/1998
Blum RH, Atkins MB, Coates AS, Kirkwood JM, Ibrahim J, Falkson CI. "Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1998 May 0; 16(5):1743-51.

1998
Falkson HC, Falkson CI. "Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992." Oncology.. 1998 55(1):59-64.

1998
Cohen GL, Falkson CI. "Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin." Oncology.. 1998 55(2):116-21.

1998
Garbers LM, Falkson CI, Falkson G. "Hepatocellular carcinoma." Cancer treatment and research.. 1998 98:83-109.

4/1997
Falkson C, Retsas S. "2nd International Conference on the Adjuvant Therapy of Malignant Melanoma. London, UK, 14-15 March, 1997. Report and abstracts." Melanoma research.. 1997 Apr 0; 7(2):153-73.

1997
Falkson G, Eek R. "The low-grade lymphoproliferative disorders." Oncology.. 1997 54(6):441-58.

12/1996
Falkson CI, Nel JS. "Granulocyte-colony stimulating factor fails to prevent leucopenia caused by CEMP in elderly patients with aggressive lymphoma." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1996 Dec 0; 86(12):1564.

11/2/1996
"Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group." Lancet.. 1996 Nov 2; 348(9036):1189-96.

9/1996
Eek R W; Falkson C I. "The low grade lymphoproliferative disorders." Specialist Medicine. 1996; : 14-23, 39.

7/1996
Falkson HC, Falkson CI. "A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer." Annals of oncology : official journal of the European Society for Medical Oncology. 1996 Jul 0; 7(5):465-9.

6/1996
Falkson CI. "Fludarabine: a phase II trial in patients with previously treated low-grade lymphoma." American journal of clinical oncology.. 1996 Jun 0; 19(3):268-70.

5/1996
Falkson G, Falkson CI, Hocepied AM. "A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1996 May 0; 86(5):549-50.

1996
Falkson G, Falkson HC, Falkson CI. "Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin." Oncology.. 1996 53(4):313-7.

1996
Falkson CI, Nel JS. "Granulocyte-macrophage-colony-stimulating factor support in patients with acute non-lymphatic leukemia." Oncology.. 1996 53(6):482-7.

12/1995
Falkson CI. "Treatment of metastatic malignant melanoma." Anti-cancer drugs.. 1995 Dec 0; 6(6):709-16.

3/1995
Falkson CI. "Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma." Medical oncology.. 1995 Mar 0; 12(1):35-40.

1995
Falkson HC, Falkson CI. "Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy." Oncology.. 1995 52(5):427-31.

1/1994
Harris J, Falkson CI, Glick J, Gelman R, Falkson G. "Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1994 Jan 0; 12(1):45-9.

1994
Falkson HC, Falkson G, Falkson CI. "Phase II trial of fotemustine in patients with metastatic malignant melanoma." Investigational new drugs.. 1994 12(3):251-4.

1994
Keren-Rosenberg S, Uys A, Falkson HC, Falkson G, Falkson CI. "FIVB plus GM-CSF in metastatic colorectal cancer." Investigational new drugs.. 1994 12(1):49-52.

1994
Vermaak WJ, Stevens K, Falkson G, Uys A, Keren-Rosenberg S, Falkson CI. "Recombinant human erythropoietin in the treatment of cancer-related anaemia." Oncology.. 1994 51(6):497-501.

7/1993
Falkson CB, Falkson CI, Falkson G. "Combined modality treatment of gastrointestinal cancer." Current opinion in oncology.. 1993 Jul 0; 5(4):710-8.

2/1993
Falkson CI. "New formulation intravenous melphalan in the treatment of patients with metastatic renal cancer." Investigational new drugs.. 1993 Feb 0; 11(1):93.

2/1993
Falkson HC, Falkson CB, Falkson G, Falkson CI. "A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer." American journal of clinical oncology.. 1993 Feb 0; 16(1):14-7.

1993
Falkson HC, Falkson G, Falkson CI. "Postmenopausal breast cancer. Drug therapy in the 1990s." Drugs & aging.. 1993 3(2):106-21.

12/1992
Falkson CI, Falkson HC, Falkson G. "Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer." Annals of oncology : official journal of the European Society for Medical Oncology. 1992 Dec 0; 3(10):849-53.

11/1992
Falkson CI, Glick J, Gelman RS, Falkson G, Harris J. "Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study." Annals of oncology : official journal of the European Society for Medical Oncology. 1992 Nov 0; 3(9):768-70.

11/1992
Falkson G, Hunt M, Borden EC, Hayes JA, Falkson CI, Smith TJ. "An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma." Investigational new drugs.. 1992 Nov 0; 10(4):337-43.

10/1992
Falkson C I. "Chemotherapy and Interferons in metastatic malignant melanoma: Will they work and why?". Cancer Therapy Update. 1992; 12(4).

1992
Falkson C I. "New developments in cancer management." Hospital and Specialist Medicine. 1992; 14(2): 16-17.

1992
Falkson G; Falkson C I. "Prevention of vomiting caused by cytotoxic drugs". Cont Medical Education. 1992; 10(12): 2053-2056, 2058, 2060.

1992
Falkson CI, Falkson G. "Current approaches in the management of patients with hepatocellular carcinoma." Oncology research.. 1992 4(3):87-9.

1992
Falkson HC, Falkson CB, Falkson G, Falkson CI. "Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer." Oncology.. 1992 49(6):418-21.

12/1991
Harris J, Glick J, Falkson CI, Gelman R, Falkson G. "Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1991 Dec 0; 9(12):2153-61.

8/1991
Falkson HC, Falkson G, Falkson CI. "Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1991 Aug 0; 9(8):1403-8.

6/15/1991
Falkson CI. "Adjuvant therapy now indicated for colorectal carcinoma." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1991 Jun 15; 79(12):692.

4/1991
Falkson HC, Falkson G, Falkson CI. "Long term follow-up of patients with advanced prostatic cancer treated with nasal buserelin." Annals of oncology : official journal of the European Society for Medical Oncology. 1991 Apr 0; 2(4):303-4.

1991
Voges C W; Falkson C I. "Serum Hormone levels in premenopausal women with breast cancer treated with adjuvant CMF or CMF + Buserelin". Eur J Cancer. 1991; : 52.

1991
de Wet M; Falkson C I; Voges C W. "Continuation of Granisetron administration in patients receiving cytostatics." Eur J Cancer. 1991; : 293.

1991
Falkson C I; Falkson C B; Falkson H C; Falkson G. "Chemotherapy treatment for carcinomas of the liver, gallbladder and bile duct and pancreas". Understanding Oncology. 1991; 24(4): 27-28, 29-32, 34.

1991
Falkson G, Falkson HC, Falkson CI. "Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer." European journal of cancer : official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR).. 1991 27(10):1208-11.

1991
Cloete EV, Gresse P, Rapoport BL, Jansen van Rensburg CE, Ansell SM, van Staden AM, Stevens K, Falkson CI, Falkson G. "Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitol." Oncology.. 1991 48(3):253-7.

11/1990
Falkson G, Falkson CI, Falkson HC. "High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting." Investigational new drugs.. 1990 Nov 0; 8(4):407-9.

10/1/1990
Falkson CI, Leone L, Gelman RS, Falkson G. "Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies." Cancer.. 1990 Oct 1; 66(7):1621-9.

1990
Falkson C I; Falkson G; Falkson H C. "Cancer Chemotherapy and Breast Cancer." Understanding Oncology. 1990; 1(3): 15,17,18.

1990
Falkson CI. "Are we making progress in the management of cancer?". Hospital Medicine. 1990; 12(7): 22-24.

1990
Falkson CI. "Are we making progress in the management of breast cancer?". Cancer Therapy Update. 1990; 10(5).

7/1989
Falkson G, Falkson HC, Falkson CI. "Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector." Investigational new drugs.. 1989 Jul 0; 7(2-3):261-7.

8/1988
Falkson G, Falkson HC, Falkson CI. "High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer." American journal of clinical oncology.. 1988 Aug 0; 11(4):431-4.

1988
Falkson G, Falkson CI, Terblanche AP, Vorobiof DA. "Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma." Oncology.. 1988 45(5):378-9.

6/1987
Cummings FJ, Wolter JM, Falkson CI, Tormey DC, Gelman RS, Falkson G. "Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1987 Jun 0; 5(6):881-9.

10/26/1985
Falkson CI. "Mesothelioma or ovarian carcinoma? A case report." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.. 1985 Oct 26; 68(9):676-7.

1985
Falkson CI. "Verslag Reis VSA September/Oktober 1984". Geneeskunde. 1985; : 102 103, 105 107.

1984
Falkson G; Falkson C I; Scherman R C; Terblanche A P S. "Oorlewing op langtermyn by pasiënte met Non Hodgkin Limfoom". Geneeskunde. 1984; 26: 323 325,327 328.

Books & Chapters

2005
Chapter Title: Adjuvant Therapy of Breast Cancer
Book Title: Breast Cancer in Women of African Descent.
Author List: Williams C, Falkson Carla
Edited By: Williams CKO, Olopade OI, Falkson CI
Published By: Springer2005 in Dordrecht,The Netherlands.

2003
Book Title: Breast Cancer
Author List: Falkson C I
Published By: Oxmoor House2003 in Birmingham, Alabama

1998
Chapter Title: Hepatocellular Carcinoma
Book Title: Cancer Treatment and Research, Gastrointestinal Oncology
Author List: Falkson G, Falkson C I, Garbers L M
Edited By: Al B Benson III
Published By: Kluwer Academic Publishers1998 in Boston

1998
Chapter Title: Cancer Pain
Book Title: MIMS Prescribing Power
Author List: Falkson C I
Edited By: J R Snyman, de K Sommers
Published By: MIMS1998 in Pretoria

1998
Chapter Title: Leukaemia.
Book Title: MIMS Disease Review
Author List: Falkson C I, Slabber F
Edited By: J R Snyman, de K Sommers
Published By: MIMS1998 in Pretoria

1998
Chapter Title: Breast Cancer
Book Title: MIMS Disease Review
Author List: Falkson C I, Eek R W
Edited By: J R Snyman, de K Sommers
Published By: MIMS1998 in Pretoria

1998
Chapter Title: Cancer Pain
Book Title: MIMS Disease Review
Author List: Falkson C I, Cohen G L
Edited By: J R Snyman, de K Sommers
Published By: MIMS1998 in Pretoria

1998
Chapter Title: Skin Cancer
Book Title: MIMS Disease Review
Author List: Falkson C I
Edited By: J R Snyman, de K Sommers
Published By: MIMS1998 in Pretoria

1996
Chapter Title: Cancer Pain
Book Title: MIMS Prescribing Power
Author List: Falkson C I.
Edited By: RJ van Royen, J R Snyman
Published By: MIMS1996 in Pretoria

1995
Chapter Title: Primary Liver Cancer
Book Title: Current Therapy in Hematology - Oncology
Author List: Falkson G, Falkson C I, Falkson C B
Edited By: Brain MC, Carbone PP
Published By: Mosby - Yearbook, Inc1995 in St. Louis, MO

1995
Chapter Title: Chemotherapy for gynecological cancer
Book Title: Manual of Practical Gynecological Oncology
Author List: Falkson C I, Falkson G.
Edited By: Basil Bloch, Katrien Dehaeck, Robbert Soeters
Published By: Chapman & Hall Medical1995 in London, UK

1995
Chapter Title: Breast Cancer
Book Title: MIMS Disease Review (First South African Edition)
Author List: Falkson C I.
Edited By: EJJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers
Published By: MIMS1995 in Pretoria

1995
Chapter Title: Leukaemia
Book Title: MIMS Disease Review (First South African Edition)
Author List: Falkson C I
Edited By: EJJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers
Published By: MIMS1995 in Pretoria

1995
Chapter Title: Lung Cancer
Book Title: MIMS Disease Review (First South African Edition)
Author List: Falkson C I
Edited By: EJJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers
Published By: MIMS1995 in Pretoria

1995
Chapter Title: Malignant lymphomas
Book Title: MIMS Disease Review (First South African Edition)
Author List: Falkson C I.
Edited By: EJJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers
Published By: MIMS1995 in Pretoria

1995
Chapter Title: Skin Cancer
Book Title: MIMS Disease Review (First South African Edition),
Author List: Falkson C I.
Edited By: EJJ van der Horst, RJ van Rooyen, JR Snyman, De K Sommers
Published By: MIMS1995 in Pretoria

1993
Book Title: Melanoma: the Disease and its Treatment.
Author List: Kirkwood J M, Falkson C I.
Published By: Oxford Clinical Communications, U.K1993

1993
Chapter Title: Hepatocarcinoma, Hepatoblastoma
Book Title: Handbook of Chemotherapy in Clinical Oncology.
Author List: Falkson G, Falkson C I, Falkson C B
Edited By: E Cvitkovic, JP Droz, JP Armand, S Khoury
Published By: Scientific Communication International Ltd,1993 in Channel Island

1993
Chapter Title: Breast Cancer
Book Title: MIMS Disease Index
Author List: Falkson C I, Green M D
Edited By: Van der Horst EJJ
Published By: IMS Publishing1993 in Crows Nest, N.S.W.

1993
Chapter Title: Leukaemias
Book Title: MIMS Disease Index
Author List: Falkson C I, Sheridan W P
Edited By: Van der Horst EJJ
Published By: IMS Publishing,1993 in Crows Nest, N.S.W

1993
Chapter Title: Lung cancer
Book Title: MIMS Disease Index
Author List: Bishop J F, Falkson C I.
Edited By: Van der Horst EJJ
Published By: IMS Publishing1993 in Crows Nest, N.S.W.

1993
Chapter Title: Lymphomas, malignant
Book Title: MIMS Disease Index
Author List: Benson W J, Falkson C I
Edited By: Van der Horst EJJ
Published By: IMS Publishing1993 in Crows Nest, N.S.W

1993
Chapter Title: Skin cancer.
Book Title: MIMS Disease Index
Author List: Falkson C I, Marks R
Edited By: Van der Horst EJJ
Published By: IMS Publishing1993 in Crows Nest, N.S.W.

1991
Chapter Title: Combination chemotherapy
Book Title: Medical Management of Breast Cancer
Author List: Falkson G, Falkson C I, Falkson H
Edited By: Powles T J, Smith I E
Published By: Martin Dunitz1991 in London, U.K